透過您的圖書館登入
IP:18.220.176.156

摘要


為瞭解台灣地區抗生素氯林絲菌素(Clindamycin)原料藥之品質狀況,由台北市政府衛生局、高雄市政府衛生局及各縣市政府衛生局,於民國96年3月至8月間,赴轄區內氯林絲菌素製劑製造廠抽驗檢體共計25件,包含12件鹽酸氯林絲菌素(Clindamycin Hydrochloride)原料藥及13件磷酸氯林絲菌素(Clindamycin Phosphate)原料藥。參照中華藥典第六版(Ch. P. VI)、美國藥典第29版(USP 29)、歐洲藥典第5.0版(EP 5.0)及英國藥典2000年版(BP 2000)之檢驗規格及方法進行檢測,其結果均符合藥典規定,結果提供衛生主管機關作為藥政管理之參考。

並列摘要


In order to survey the quality of clindamycin active pharmaceutical ingredient (API), 25 samples were collected by local health authorities from March to August, 2007 and analyzed according to the methods described in the Ch. P. VI, USP 29, EP 5.0 and BP 2000. The results showed that all samples including 12 clindamycin hydrochloride samples and 13 clindamycin phosphate samples met the pharmacopeia requirements.

延伸閱讀